ADMA Biologics, Inc. - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by ADMA Biologics, Inc. on October 22, 2019. The company is incorporated in Delaware and its common stock trades on the Nasdaq Global Market under the symbol "ADMA". The report addresses a specific corporate event occurring on the filing date.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is a Current Report regarding a specific event and does not contain financial statements or performance metrics.
Material Changes
There are no material financial changes reported in this document. The filing discloses a non-financial corporate event: ADMA Biologics was named "Company of the Year" by BioFlorida.
Guidance, Outlook, and Risks
The filing contains no management guidance, financial outlook, risk factors, or discussion of contingencies. The content is limited to the announcement of the award and the inclusion of the associated press release as Exhibit 99.1.
Key Facts for Investors
- Event: ADMA Biologics was recognized as "Company of the Year" by BioFlorida on October 22, 2019.
- Documentation: The full press release detailing the award is filed as Exhibit 99.1.
- Financial Data: No financial data or operational metrics are included in this specific filing.
- Signatory: The report was signed by Brian Lenz, Executive Vice President and Chief Financial Officer.